變化即將來(lái)臨，歐洲藥品質(zhì)量管理局?(EDQM)近日宣布，歐洲藥典許可和出版模式即將迎來(lái)重大更新。

即將到來(lái)的變化將使歐洲藥典的訪(fǎng)問(wèn)和使用變得更容易，更環(huán)保，并能更好地滿(mǎn)足您多年來(lái)的需求和要求。

從第?EP12.1開(kāi)始，歐洲藥典將完全在線(xiàn)提供，所有文本都可在改進(jìn)的、用戶(hù)友好的平臺(tái)上供訂閱者使用。會(huì)用一種更直觀(guān)的方法，更現(xiàn)代化的界面，快速高效地訪(fǎng)問(wèn)所需的內(nèi)容，具有更強(qiáng)的搜索功能、高效的儀表板、新的過(guò)濾器和屬性等等。

新的年度版本由三卷組成（編號(hào)12.1-12.3），對(duì)應(yīng)2025年歐洲藥典委員會(huì)會(huì)議在其中通過(guò)的新文本和修訂文本，將取代以前三年一個(gè)版本，八個(gè)增補(bǔ)的更新周期。

此外，將引入365天的許可模式，簡(jiǎn)化許可管理。歐洲藥典將過(guò)渡到新的平臺(tái)和出版模式，以便順利進(jìn)行這些更改。

所有第11版的訂閱將在過(guò)渡期內(nèi)有效，直至2025年底。

自2026年1月1日起，僅新平臺(tái)可用。

我公司是歐洲藥典委員會(huì)（EDQM）簽約分銷(xiāo)商(以旗下公司名義)，具體資質(zhì)可聯(lián)系我公司查看。

我司將及時(shí)推送關(guān)于歐洲藥典的最新消息，也歡迎廣大客戶(hù)聯(lián)系我們訂閱購(gòu)買(mǎi)。

注意：基于稅務(wù)要求，有關(guān)進(jìn)口產(chǎn)品的銷(xiāo)售我司可能會(huì)用旗下公司抬頭與您簽訂合同、結(jié)算和開(kāi)票，以方便報(bào)稅記賬，請(qǐng)知悉。

歐洲藥品質(zhì)量管理局通知原文

Change is in the air, and the European Directorate for the Quality of Medicines & HealthCare (EDQM) would like to give you, as an important stakeholder, advance notice of the improvements coming to the European Pharmacopoeia licencing and publication models. The upcoming changes will make it easier to access and use, more environmentally friendly and better able to meet your requirements and needs for many years to come.

Starting with Issue 12.1, the European Pharmacopoeia will be available exclusively online, with all texts available to subscribers on an improved, user-friendly platform. You will discover a more visual approach with a modern, intuitive interface for quick and efficient access to the content you need, featuring enhanced search capabilities, a time-saving dashboard, new filters and attributes, and much more.

An annual edition consisting of three issues (numbered 12.1 to 12.3), corresponding to the European Pharmacopoeia Commission sessions in 2025 at which new and revised texts are adopted, will replace the former three-year cycle comprising one edition and eight supplements. Likewise, a 365-day licencing model will be introduced, with simplified licence management.

The European Pharmacopoeia will transition to the new platform and publication models to ease in the changes. All subscriptions to the 11th Edition will remain valid during the transitional period until the end of 2025. As of 1 January 2026, only the new platform will be available.